Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice

Cancer therapy-related pulmonary hypertension is a rare yet potentially fatal cardiotoxicity. However, it is a reversible cause of pulmonary hypertension if detected in its early stages. Cancer therapy-related pulmonary hypertension has been encountered in patients using tyrosine kinase inhibitors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürdoğan, Muhammet, Demir, Melik, Yalta, Kenan, Gürlertop, Yekta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Cardiology 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250770/
https://www.ncbi.nlm.nih.gov/pubmed/37257013
http://dx.doi.org/10.14744/AnatolJCardiol.2023.3013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250770/
https://www.ncbi.nlm.nih.gov/pubmed/37257013
http://dx.doi.org/10.14744/AnatolJCardiol.2023.3013

Ejemplares similares